A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo

2017/04/06 by Mohit Verma, Mohit K. Verma, Julia Clemens +5 · 27 citations
Immunology and Microbiology · Medicine · #Complement system in diseases #Monoclonal and Polyclonal Antibodies Research #Immune Cell Function and Interaction

paper · doi:10.1016/j.jim.2017.03.021

Citations

• Mouse strains with typical mammalian levels of complement activity

Cited by

• Follicular helper- and peripheral helper-like T cells drive autoimmune disease in human immune system mice
• T Cell Development and Responses in Human Immune System Mice
• Complement in cancer: untangling an intricate relationship. [europepmc]
• The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model. [europepmc]
• Complement as a Biological Tool to Control Tumor Growth. [europepmc]
• Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity. [europepmc]
• Development of an Adrenocortical Cancer Humanized Mouse Model to Characterize Anti-PD1 Effects on Tumor Microenvironment. [europepmc]
• In Vivo Analysis of Human Immune Responses in Immunodeficient Rats. [europepmc]
• Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease, and Regenerative Medicine. [europepmc]
• Improved mouse models and advanced genetic and genomic technologies for the study of neutrophils. [europepmc]
• The Development of Next-generation PBMC Humanized Mice for Preclinical Investigation of Cancer Immunotherapeutic Agents. [europepmc]
• Use of Humanized Mouse Models to Investigate the Roles of Purinergic Signaling in Inflammation and Immunity. [europepmc]
• The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs. [europepmc]
• Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. [europepmc]
• Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model. [europepmc]
• Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections. [europepmc]
• Modeling human T1D-associated autoimmune processes. [europepmc]
• Endemic Burkitt lymphoma avatar mouse models for exploring inter-patient tumor variation and testing targeted therapies. [europepmc]
• Dirofilariasis mouse models for heartworm preclinical research. [europepmc]
• Current status of immunodeficient mouse models as substitutes to reduce cat and dog use in heartworm preclinical research. [europepmc]
• T Cell Development and Responses in Human Immune System Mice. [europepmc]
• The Anti-Human P2X7 Monoclonal Antibody (Clone L4) Can Mediate Complement-Dependent Cytotoxicity of Human Leukocytes. [europepmc]
• Follicular helper- and peripheral helper-like T cells drive autoimmune disease in human immune system mice. [europepmc]
• Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies. [europepmc]
• Transgenic expression of human CD47 on pig cells provides only partial protection against human macrophage-mediated destruction in human immune system mice. [europepmc]
• Selective Depletion of Autoreactive Plasma Cells as a Novel Strategy to Treat Acetylcholine Receptor Antibody-Positive Myasthenia Gravis. [europepmc]
• Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic function. [europepmc]